# Radical Numerics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/radical-numerics

- Industry: Software
- Headquarters: Menlo Park, US
- Website: www.radicalnumerics.ai
- Total disclosed funding: $50M
- Latest round: Seed (Jun 15, 2026)
- Investors on record: 5

## About

Radical Numerics, Inc., based in the US, is focused on developing advanced artificial intelligence solutions that aim to achieve general biological intelligence, serving various sectors including healthcare and agriculture.Founded in 2025 and headquartered in Menlo Park, US, Radical Numerics, Inc. specializes in pioneering AI technologies. The company has participated in two funding rounds, culminating in a Seed round where it successfully raised USD 50.00 mn led by Emergence Capital, which included participation from Factory, First Spark Ventures, Obvious, and Triatomic Capital. The founder's information is not provided, but the company has established a foothold in the AI landscape through its innovative offerings.Radical Numerics develops next-generation AI solutions aimed at achieving general biological intelligence. Its core product, the Omnii research preview, provides early access to groundbreaking AI technologies designed to tackle complex biological challenges across healthcare, agriculture, and environmental science. The company serves a diverse clientele, including research institutions and biotechnology firms across North America, Europe, and Asia, catering to the increasing demand for advanced AI tools in biological research and development.Radical Numerics generates revenue through partnerships and subscription-based access to its AI products, enabling clients to utilize the Omnii platform's advanced features. Revenue is driven by direct agreements that include collaborative research endeavors, and its pricing strategy aligns with industry standards for similar AI solutions, offering varied access tiers to meet clients' needs in the biotechnology and research sectors.Radical Numerics plans to expand its product line with upcoming releases of enhanced AI tools aimed at specific biological applications. The company is targeting expansion into new markets across Asia and Europe by 2026, leveraging the recent funding of USD 50.00 mn from its Seed round to support these initiatives. Additionally, the firm aims to deepen partnerships and broaden its client base to further enhance its market presence.

## Funding rounds

- Seed, Jun 15, 2026, $50M — Emergence Capital, Obvious, Factory, First Spark Ventures, Triatomic Capital

## Investors

- Emergence Capital (https://capitalatlas.ai/funds/emergence-capital) — Seed
- Obvious (https://capitalatlas.ai/funds/obvious) — Seed
- Factory (https://capitalatlas.ai/funds/factory) — Seed
- First Spark Ventures (https://capitalatlas.ai/funds/first-spark-ventures) — Seed
- Triatomic Capital (https://capitalatlas.ai/funds/triatomic-capital) — Seed